{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:56:11Z","timestamp":1761393371546,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaoning Nature Science Foundation","award":["201702851"],"award-info":[{"award-number":["201702851"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid carcinoma is the most common malignant endocrine tumour, and its prevalence has been on the rise in recent years. However, mechanisms underlying the metastasis of thyroid carcinoma and candidate biomarkers remain elusive. In this study, we screened genes involved in the virulence and metastasis of papillary thyroid carcinoma (PTC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Oxford Nanopore Technology full-length transcriptome sequencing and bioinformatic analyses were performed to analyse differentially expressed genes (DEGs) in PTC. We collected 15 cancerous and paracancerous tissue pairs from patients with PTC for RNA sequencing. The significance thresholds for DEGs were |log2(fold change)| \u2265 1 and false discovery rate (FDR)\u2009&lt;\u20090.01. Gene Ontology and Kyoto Encyclopaedia Gene and Genome pathway enrichment analyses of the 50 most significant DEGs were performed. Immunohistochemistry was used to evaluate\n                      <jats:italic>LAMB3<\/jats:italic>\n                      expression in tissue microarrays (58 pairs of PTC samples) and its correlation with clinicopathological parameters. Differences in gene expression between cancerous and paracancerous tissues were analysed using the Wilcoxon test. The correlation between gene expression and clinical variables was assessed using Fisher\u2019s exact test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis revealed the presence of 1,687 DEGs in PTC, and the expression of 804 and 883 genes was found to be upregulated and downregulated, respectively.\n                      <jats:italic>LAMB3<\/jats:italic>\n                      expression was significantly elevated in cancerous tissues when compared to that in paracancerous tissues (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                      <jats:italic>LAMB3<\/jats:italic>\n                      expression was significantly positively associated with PTC tumour tissue size (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.49) and T stage (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.339).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings suggest that\n                      <jats:italic>LAMB3<\/jats:italic>\n                      expression significantly increases in PTC and it is associated with tumor size and T stage.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-14916-0","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:52:16Z","timestamp":1761393136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Full-length transcriptome analysis of papillary thyroid carcinoma reveals correlation between LAMB3 expression and clinical features"],"prefix":"10.1186","volume":"25","author":[{"given":"Shang","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zimeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"14916_CR1","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/s0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783\u201395. https:\/\/doi.org\/10.1016\/s0140-6736(16)30172-6.","journal-title":"Lancet"},{"key":"14916_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1200\/JCO.2017.74.5497","volume":"36","author":"X Shen","year":"2018","unstructured":"Shen X, Zhu G, Liu R, Viola D, Elisei R, Puxeddu E, et al. Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J Clin Oncol. 2018;36:438\u201345. https:\/\/doi.org\/10.1200\/JCO.2017.74.5497.","journal-title":"J Clin Oncol"},{"key":"14916_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M. New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne). 2020;11:82. https:\/\/doi.org\/10.3389\/fendo.2020.00082.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14916_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-008-9260-4","volume":"20","author":"BA Kilfoy","year":"2009","unstructured":"Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence. 1973\u20132002. Cancer Causes Control. 2009;20:525\u201331. https:\/\/doi.org\/10.1007\/s10552-008-9260-4.","journal-title":"Cancer Causes Control"},{"key":"14916_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF03346587","volume":"33","author":"H Gharib","year":"2010","unstructured":"Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Heged\u00fcs L, et al. American association of clinical endocrinologists, associazione Medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Investig. 2010;33:287\u201391. https:\/\/doi.org\/10.1007\/BF03346587.","journal-title":"J Endocrinol Investig"},{"issue":"17","key":"14916_CR6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMcp031436","volume":"351","author":"L Heged\u00fcs","year":"2004","unstructured":"Heged\u00fcs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351(17):1764\u201371. https:\/\/doi.org\/10.1056\/NEJMcp031436.","journal-title":"N Engl J Med"},{"key":"14916_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bjorl.2017.02.002","volume":"84","author":"Y Al-Ammar","year":"2018","unstructured":"Al-Ammar Y, Al-Mansour B, Al-Rashood O, Tunio MA, Islam T, Al-Asiri M, et al. Impact of body mass index on survival outcome in patients with differentiated thyroid cancer. Braz J Otorhinolaryngol. 2018;84:220\u20136. https:\/\/doi.org\/10.1016\/j.bjorl.2017.02.002.","journal-title":"Braz J Otorhinolaryngol"},{"key":"14916_CR8","doi-asserted-by":"publisher","unstructured":"Kwon OH, Park JL, Kim M, Kim JH, Lee HC, Kim HJ, et al. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun. 2011;406:539\u201345. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.082.","DOI":"10.1016\/j.bbrc.2011.02.082"},{"key":"14916_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3892\/ijo.2011.1048","volume":"39","author":"M Ii","year":"2011","unstructured":"Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, et al. Co-expression of laminin beta3 and gamma2 chains and epigenetic inactivation of laminin alpha3 chain in gastric cancer. Int J Oncol. 2011;39:593\u20139. https:\/\/doi.org\/10.3892\/ijo.2011.1048.","journal-title":"Int J Oncol"},{"key":"14916_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1593\/neo.03499","volume":"6","author":"R Calaluce","year":"2004","unstructured":"Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, et al. Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumourigenicity. Neoplasia. 2004;6:468\u201379. https:\/\/doi.org\/10.1593\/neo.03499.","journal-title":"Neoplasia"},{"key":"14916_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.18632\/oncotarget.709","volume":"3","author":"T Kinoshita","year":"2012","unstructured":"Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, Yoshino H, et al. Tumour suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget. 2012;3:1386\u2013400. https:\/\/doi.org\/10.18632\/oncotarget.709.","journal-title":"Oncotarget"},{"key":"14916_CR12","doi-asserted-by":"publisher","unstructured":"Liu L, Jung SN, Oh C, Lee K, Won HR, Chang JW, et al. LAMB3 is associated with disease progression and cisplatin cytotoxic sensitivity in head and neck squamous cell carcinoma. Eur J Surg Oncol. 2019;45:359\u201365. https:\/\/doi.org\/10.1016\/j.ejso.2018.10.543.","DOI":"10.1016\/j.ejso.2018.10.543"},{"key":"14916_CR13","doi-asserted-by":"publisher","unstructured":"Reis ST, Timoszczuk LS, Pontes-Junior J, Viana N, Silva IA, Dip N, et al. The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer. Clin (Sao Paulo). 2013;68:652\u20137. https:\/\/doi.org\/10.6061\/clinics\/2013(05)12.","DOI":"10.6061\/clinics\/2013(05)12"},{"key":"14916_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.cellbio.20.010403.094555","volume":"20","author":"JH Miner","year":"2004","unstructured":"Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255\u201384. https:\/\/doi.org\/10.1146\/annurev.cellbio.20.010403.094555.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"14916_CR15","doi-asserted-by":"publisher","unstructured":"Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, et al. Polymorphisms involved in the miR-218- LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol. 2010;117:287\u201390. https:\/\/doi.org\/10.1016\/j.ygyno.2010.01.020.","DOI":"10.1016\/j.ygyno.2010.01.020"},{"key":"14916_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1320-z","volume":"10","author":"H Zhang","year":"2019","unstructured":"Zhang H, Pan Y-Z, Cheung M, Cao M, Yu C, Chen L, et al. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K\/Akt signalling pathway. Cell Death Dis. 2019;10:230. https:\/\/doi.org\/10.1038\/s41419-019-1320-z.","journal-title":"Cell Death Dis"},{"key":"14916_CR17","doi-asserted-by":"publisher","unstructured":"Wang XM, Li J, Yan MX, Liu L, Jia DS, Geng Q, et al. Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer. PLoS One. 2013;8:e55714. https:\/\/doi.org\/10.1371\/journal.pone.0055714.","DOI":"10.1371\/journal.pone.0055714"},{"key":"14916_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/0470857897.ch8","volume-title":"The KEGG database. Chichester","author":"M Kanehisa","year":"2002","unstructured":"Kanehisa M. The KEGG database. Chichester. UK: Wiley; 2002. https:\/\/doi.org\/10.1002\/0470857897.ch8."},{"key":"14916_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1083\/jcb.200401058","volume":"164","author":"T Sasaki","year":"2004","unstructured":"Sasaki T, Fassler R, Hohenester E. Laminin: the crux of basement membrane assembly. J Cell Biol. 2004;164:959\u201363. https:\/\/doi.org\/10.1083\/jcb.200401058.","journal-title":"J Cell Biol"},{"key":"14916_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nrc2089","volume":"7","author":"MP Marinkovich","year":"2007","unstructured":"Marinkovich MP. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer. 2007;7:370\u201380.https:\/\/doi.org\/10.1038\/nrc2089.","journal-title":"Nat Rev Cancer"},{"key":"14916_CR21","doi-asserted-by":"publisher","unstructured":"Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, et al. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer. Onco Targets Ther. 2018;11:37\u201346.\u00a0https:\/\/doi.org\/10.2147\/OTT.S149613.","DOI":"10.2147\/OTT.S149613"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14916-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:52:17Z","timestamp":1761393137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14916-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14916"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14916-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research was authorised by the Ethics Council of The Third Attached Hospital of Jinzhou Medical University (approval no. KX2021011). The tissue microarray was authorised by the Ethics Council of Shanghai Outdo Biotech Co., Ltd. (approval number SHYJS-CP-1907007). Each study participant voluntarily provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1646"}}